Influence
August 25, 2020

Regenstrief CEO provides feedback to NLM on needs of health services researchers

Peter Embí, M.D., M.S., president and chief executive officer of Regenstrief Institute, was one of three people on a National Library of Medicine (NLM) panel to discuss the current and future needs of health services researchers.

Since the early 1990s and the establishment of the  National Information Center on Health Services Research and Health Care Technology (NICHSR), NLM has taken steps to ensure that its general activities and its core collections of journals, books and manuscripts reflect the current state of health services research. Additionally, NLM has developed specialized tools, resources and activities targeted toward the health services research community to address challenges in accessing certain information understood to be needed by the researchers.

During the webinar, Dr. Embí discussed how he and his colleagues at Regenstrief and Indiana University School of Medicine use the current tools and resources, which are the most critical and which research and policy areas need NLM focus and support.

Dr. Embí was joined on the panel by Anthony K. Wutoh, PhD, provost and chief academic officer at Howard University and Nate C. Apathy, PhD, a former pre-doctoral fellow at Regenstrief and Indiana University Richard M. Fairbanks School of Public Health at IUPUI and currently a postdoctoral fellow at the University of Pennsylvania.

Related News

(From left to right) Dr. Brian Dixon, Dr. Sanji De Sylva and Isaac Vetter. Photo credit: Svetlana Efimova

Regenstrief experts advance global dialogue on digital health and interoperability at forum in Dubai

Regenstrief informaticians joined global leaders who shared their expertise at the 8th ZIMAM Digital Health Forum November 5-6, in

Regenstrief researchers join national stage to advance aging and gerontology research

Regenstrief Institute research scientists joined leading experts from across the nation at the Gerontological Society of America (GSA) 2025

illustration of the combination of interventions used in the D3 pragmatic clinical trial

Zero-cost, AI-driven digital detection identifies Alzheimer’s and related dementias without additional clinician time

Few primary care practices are designed for the timely detection of Alzheimer’s disease and related dementias. The limited time